Side-by-side comparison of AI visibility scores, market position, and capabilities
Cannabis seed-to-sale tracking and compliance software used by state regulators and licensed operators to monitor inventory through the full supply chain. Fort Lauderdale, FL.
BioTrackTHC is a Fort Lauderdale, Florida-based cannabis technology company specializing in seed-to-sale tracking and compliance software for both government regulators and licensed cannabis operators. The company is notable for having been selected by multiple state cannabis regulatory agencies to build and operate the official state traceability systems used to track cannabis from cultivation through processing, distribution, and retail sale. This regulatory-side business distinguishes BioTrackTHC from vendors that serve only licensed businesses.\n\nOn the operator side, BioTrackTHC provides dispensary and cultivator software that integrates directly with state-mandated tracking systems, simplifying compliance reporting for licensed cannabis businesses. Because the company built and operates several state systems, its operator software products benefit from deep familiarity with the technical requirements and data exchange protocols of government traceability infrastructure. This regulatory expertise is a meaningful competitive advantage when selling to operators who prioritize compliance reliability above other software features.\n\nBioTrackTHC has been acquired by Forian Inc. (FORA), becoming part of a broader data and analytics holding company. The cannabis industry's regulatory environment continues to evolve as more states legalize adult-use cannabis, creating ongoing demand for compliant tracking solutions. BioTrackTHC has operated state systems in Washington, New Mexico, Hawaii, Illinois, and several other jurisdictions, giving it a unique vantage point on regulatory requirements that informs its commercial software products.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.